Newsletters

FDA

Abortion

The Public Has Much More Trust in the FDA Than the Courts When It Comes to Abortion Access Decisions

A photo illustration of packages of mifepristone tablets
Abortion

Nearly Half of the Public Opposes Texas Judge’s Decision to Overturn FDA’s Approval of Abortion Pill

Image of mifepristone, one of the two drugs used in a medication abortion
Abortion

Many Americans Would Oppose a Ruling That Blocks FDA-Approved Abortion Pill

Photograph of the Food and Drug Administration
COVID-19

The FDA Is Considering a New COVID-19 Vaccination Strategy. Roughly Half the Public Appears to Be OK With It

FDA

About 2 in 3 Voters Back FDA Bans on Tobacco-Flavored Vapes

Baby formula supply chain issues
Children

What’s to Blame for the Baby Formula Shortage? According to Voters, It’s Mostly Supply Chain Issues

FDA

Roughly 3 in 5 Voters Back FDA Plan to Ban Menthol Cigarette Sales

COVID-19

The FDA Is Expected to Authorize COVID-19 Antiviral Pills. 3 in 4 Adults Say They’d Take Them if They Got Sick

COVID-19

Over 1 in 4 Adults Say FDA’s COVID-19 Decisions Are Politically Influenced as Agency Faces Scrutiny

AboutCareersMorning Consult IntelligenceCustom Research IntelligenceRequest a Demo
© 2023 Morning Consult, All Rights Reserved. The M Logo and MORNING CONSULT are registered trademarks of Morning Consult Holdings, Inc.
Privacy PolicySecurityDo Not Sell or Share My Personal Information California Privacy Notice